Krishna Institute of Medical Sciences Ltd

Q4 FY26Healthcare Services

Krishna Institute of Medical Sciences Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹782

Market cap₹33.7K Cr

P/E161.5

Updated23 Aug 2026

Read5 min read

The short version

KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana. The company expects a steady expansion over the next 3 to 5 years, aiming to maintain similar growth levels as in the past five years.

From Krishna Institute of Medical Sciences Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

KIMS Hospitals expects steady expansion over the next 3 to 5 years with both Greenfield and Brownfield projects in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana.
New hospitals in Bangalore (Mahadevapuram, Electronic City) and Telangana (Kondapur, Kompally) are expected to ramp up and become EBITDA positive, contributing to volume-driven growth in the next 4-5 years.
IP and OP volumes grew by 15.4% and 25.4% respectively in FY '26, with sustained upward trends anticipated.
Bangalore hospitals' occupancy expected to reach 35-40% by end of next financial year, with ARPOB stabilizing around INR 75,000 initially and improving over time.
Telangana cluster anticipates healthy EBITDA growth of around 10%-12% in FY '27.

2 more points management made on revenue & sales performance

Profitability & Margins

The company expects a steady expansion over the next 3 to 5 years, aiming to maintain similar growth levels as in the past five years.
EBITDA losses from new hospitals, currently around INR 120 crore annually, are expected to reduce to less than half in FY '27 and '28.
Telangana cluster to grow healthily with an estimated 10%-12% EBITDA growth in FY '27.
New units like Mahadevapuram and PES (Electronic City) in Bangalore are anticipated to become EBITDA positive before October and by end of financial year respectively.
Debt to EBITDA ratio targeted to reduce from current 1:3 to a healthier 1:2 to improve financial health.

2 more points management made on profitability & margins

See what Krishna Institute of Medical Sciences Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The company plans steady expansion, including both Greenfield and Brownfield projects, over the next 3-5 years.
Next 12-24 months focus on consolidating current hospitals and expanding margins.
Greenfield projects planned in Karnataka, Kerala, Tamil Nadu (1 new hospital), Andhra Pradesh, and Telangana.
Expansion involves adding more beds year-on-year; beds at Kondapur new facility to be commissioned in phases (400-500 beds in Phase 1, remaining 300 phased based on occupancy).
Remaining CAPEX of around INR 50-75 crores for Kondapur to be incurred in FY '28 and beyond.
Acquisitions of smaller hospitals (approx. 400-500 beds collectively) possible within next two quarters.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

KIMS Hospitals is planning a Qualified Institutional Placement (QIP) to raise around INR 1,500 crores.
The QIP proceeds will primarily be used to retire debt (around INR 1,000 crores) and support some losses and additional CAPEX in existing facilities.
The current net debt is around INR 3,000 crores post-QIP, and the goal is to bring the net debt to EBITDA ratio from 1:3 down to a healthier 1:2 level.
The company intends to use freed-up cash flow post-debt reduction to fund greenfield expansions, primarily in Karnataka, Kerala, Andhra Pradesh, and Telangana.

2 more points management made on fundraising & capital structure

See what Krishna Institute of Medical Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention current or expected orderbook or pending orders for KIMS Hospitals. However, relevant information related to expansions and acquisitions includes: - Ongoing and planned expansions in Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, and Telangana with greenfield and brownfield projects. - Small acquisition opportunities totaling around 400-500 beds expected over the next two quarters. - Focus on ramping up new hospitals with delays primarily due to insurance empanelment processes rather than order inflows.

2 more points management made on order book & pipeline

Krishna Institute of Medical Sciences Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.1K Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Krishna Institu.'s management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Gaudium IVF (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Krishna Institute of Medical Sciences Ltd Q4 FY26 results?

What is Krishna Institute of Medical Sciences Ltd share price analysis?

Krishna Institute of Medical Sciences Ltd currently shows a neutral. The stock trades at a P/E of 161.5 with a market cap of ₹33,691 Cr. Investors should review the full earnings analysis for detailed insights.

Is Krishna Institute of Medical Sciences Ltd planning capital expenditure?

The company plans steady expansion, including both Greenfield and Brownfield projects, over the next 3-5 years. - Next 12-24 months focus on consolidating current hospitals and expanding margins. - Greenfield projects planned in Karnataka, Kerala, Tamil Nadu (1 new hospital), Andhra Pradesh, and Telangana. - Expansion involves adding more beds year-on-year; beds at Kondapur new facility to be commissioned in phases (400-500 beds in Phase 1, remaining 300 phased based on occupancy). - Remaining CAPEX of around INR 50-75 crores for Kondapur to be incurred in FY '28 and beyond. - Acquisitions of smaller hospitals (approx.

Keep Krishna Institute of Medical Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.